Key Highlights:
- Canary Capital proposes new ETF tied to Injective (INJ) with staking
- Fund would let holders earn staking rewards on INJ
- Staked ETF trend gaining momentum as SEC weighs broader staking approvals
- Global access and lower technical barriers part of Canary’s strategy
ETF Targets Layer-1 Blockchain INJ
Canary Capital has submitted a request to the SEC for a new ETF that would track Injective (INJ), a decentralized Layer-1 blockchain, while also enabling staking to generate yield. This comes amid rising demand for altcoin investment vehicles in regulated markets.
The ETF would track INJ price and let investors earn rewards through staking, making it easier for both institutional and retail investors to access yield-bearing exposure to the Injective ecosystem.
Altcoin Staking ETFs Gaining Traction
Canary isn’t alone. Other asset managers like 21Shares and Grayscale are also pushing to include staking in their funds. Injective co-founder Eric Chen says the strategy aligns incentives—investors earn yield while supporting the network.
This U.S. filing follows 21Shares' European listing of a staked INJ product last year. If approved, Canary’s fund would extend access to global investors through a U.S.-compliant vehicle.
